International Psoriasis Council

Advancing Knowledge. Improving Care.

2026 IPC Psoriasis Masterclass – North America

Chicago, Illinois | April 11 - 12, 2026

This Masterclass is supported in part by:

The AbbVie logo, designed for IPC partners, features the company name in lowercase, modern black lettering on a white background.
The logo of Eli Lilly and Company, featured by IPC partners, displays the word Lilly in an elegant red cursive script on a white background.
Sun Pharma logo featuring an orange and beige circular design on the left, with the words SUN PHARMA in bold, black capital letters to the right—reflecting a masterclass in pharmaceutical branding.
The image shows the Takeda logo, featuring the word Takeda in red, italicized font inside a red curved arch with pointed ends on a white background, representing its association with IPC partners.
Blue and white UCB logo next to the slogan: Inspired by patients. Driven by science. on a white background, highlighting collaboration with IPC partners.

What's New

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Wednesday, May 27, 2026